131 related articles for article (PubMed ID: 21349952)
1. Scan? Cure? Sure!
Goldberg RM; Ryan DP
Oncologist; 2011; 16(2):254-6. PubMed ID: 21349952
[TBL] [Abstract][Full Text] [Related]
2. Successful combination therapy of radical liver resection with 5-fluorouracil/leucovorin, oxaliplatin, plus bevacizumab for ascending colon cancer with pulmonary and 43 liver metastases: report of a case.
Ochiai T; Masuda T; Yagi M; Kasai R; Furuyama T; Tsukamoto K; Ito H; Igari K; Aihara A; Kumagai Y; Iida M; Odajima H; Tanaka S; Arii S; Yamazaki S
Int Surg; 2012; 97(1):6-13. PubMed ID: 23101994
[TBL] [Abstract][Full Text] [Related]
3. [A case of advanced colon cancer successfully treated with combination therapy of cetuximab and oxaliplatin, leucovorin, and 5-fluorouracil].
Ojima E; Nakano T; Kanamoto A; Sasaki S
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1962-4. PubMed ID: 24393980
[TBL] [Abstract][Full Text] [Related]
4. [A case of local recurrence of colon cancer responding to chemotherapy with low-dose oxaliplatin, 5-FU and l-LV].
Seki H; Kurihara E; Iwata K; Saito J
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1291-3. PubMed ID: 17687216
[TBL] [Abstract][Full Text] [Related]
5. [COMPLETE RESECTION OF URACHAL CARCINOMA WITH SIGMOID COLON INVASION AFTER FOLFOX CHEMOTHERAPY: A CASE REPORT].
Ito A; Takata R; Matsuo T; Kimura T; Otsuka K; Ishii S; Tokiwa S; Tanji S; Sugimura J; Omori S; Obara W
Nihon Hinyokika Gakkai Zasshi; 2018; 109(1):35-39. PubMed ID: 30662050
[TBL] [Abstract][Full Text] [Related]
6. Possibility of sandwiched liver surgery with molecular targeting drugs, cetuximab and bevacizumab on colon cancer liver metastases: a case report.
Toyama Y; Ushigome T; Watanabe K; Kitamura H; Onda S; Saito R; Yoshida S; Kawahara H; Yanagisawa S; Yanaga K
World J Surg Oncol; 2012 Jun; 10():129. PubMed ID: 22747970
[TBL] [Abstract][Full Text] [Related]
7. [A case of metastatic colon cancer to paraaortic lymph nodes and liver treated successfully with oxaliplatin combination chemotherapy].
Hoshina K; Kobayashi I; Kuwano H; Kurita M; Shida D; Shinkai H; Miyashita M
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1135-7. PubMed ID: 17637557
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of serum vascular endothelial growth factor, basic fibroblast growth factor and nitric oxide in patients with colorectal carcinoma.
Akbulut H; Altuntas F; Akbulut KG; Ozturk G; Cindoruk M; Unal E; Icli F
Cytokine; 2002 Nov; 20(4):184-90. PubMed ID: 12543084
[TBL] [Abstract][Full Text] [Related]
9. Conversion treatment of hepatic metastases of colon adenocarcinoma by bevacizumab and FOLFOX.
Leite D; Kater FR
Anticancer Drugs; 2011 Jun; 22 Suppl 2():S1-7. PubMed ID: 21768791
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors and the role of adjuvant chemotherapy in post-curative surgery for Dukes B and C colon cancers and survival outcomes: a Malaysian experience.
Hassan AS; Naicker M; Yusof KH; Wan Ishak WZ
Asian Pac J Cancer Prev; 2015; 16(6):2237-43. PubMed ID: 25824744
[TBL] [Abstract][Full Text] [Related]
11. [Individualized therapy of synchronous ovarian and colon cancers with lymph].
Deme D; Bishr AM; Nizar J; Telekes A
Orv Hetil; 2015 Jun; 156(23):939-43. PubMed ID: 26027602
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of a transient increase in carcinoembryonic antigen and carbohydrate antigen 19-9 in patients with metastatic colorectal cancer receiving chemotherapy].
Li YH; An X; Xiang XJ; Wang ZQ; Wang FH; Feng F; Jiang WQ; He YJ; Xu RH
Ai Zheng; 2009 Sep; 28(9):939-44. PubMed ID: 19728911
[TBL] [Abstract][Full Text] [Related]
13. Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in Korea.
Kim JY; Kim YJ; Lee KW; Lee JS; Kim DW; Kang SB; Lee HS; Jang NY; Kim JS; Kim JH
Jpn J Clin Oncol; 2013 Feb; 43(2):132-8. PubMed ID: 23204187
[TBL] [Abstract][Full Text] [Related]
14. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
[TBL] [Abstract][Full Text] [Related]
15. [A case of advanced colon cancer responding to l-LV+5-FU as neoadjuvant chemotherapy].
Ishiyama T; Nakamura T; Suzuki T; Inazawa K
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1097-9. PubMed ID: 15272593
[TBL] [Abstract][Full Text] [Related]
16. Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials.
Schmoll HJ; Twelves C; Sun W; O'Connell MJ; Cartwright T; McKenna E; Saif M; Lee S; Yothers G; Haller D
Lancet Oncol; 2014 Dec; 15(13):1481-1492. PubMed ID: 25456367
[TBL] [Abstract][Full Text] [Related]
17. Elevated carcinoembryonic antigen and sarcoidosis masquerading as metastatic colon cancer.
Gallagher DJ; Libby DM; Kemeny N
Clin Colorectal Cancer; 2009 Jul; 8(3):172-4. PubMed ID: 19632934
[TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin-associated sarcoid-like reaction masquerading as recurrent colon cancer.
Aedma SK; Chidharla A; Kelting S; Kasi A
BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32907862
[TBL] [Abstract][Full Text] [Related]
19. Liver resection after FOLFOX with bevacizumab.
Mickle M; Mulcahy MF
Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):12-4. PubMed ID: 17491587
[No Abstract] [Full Text] [Related]
20. The effect of DNA mismatch repair (MMR) status on oxaliplatin-based first-line chemotherapy as in recurrent or metastatic colon cancer.
Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Chun HK; Lee WY; Park YS
Med Oncol; 2010 Dec; 27(4):1277-85. PubMed ID: 19949897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
